Pharmaceuticals market research reports by GlobalData

• Polycystic Kidney Disease - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Polycystic Kidney Disease - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease - Global Clinical Trials Review, 2024 provides an overview of Polycystic Kidney Disease Clinical trials scenario. This report provides top line data relating to the ... Read More

• Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024 provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top li ... Read More

• Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024 provides an overview of Dry (Atrophic) Macular Degeneration Clinical trials scenario. This report provides ... Read More

• Hyperglycemia - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Hyperglycemia - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hyperglycemia - Global Clinical Trials Review, 2024 provides an overview of Hyperglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Re ... Read More

• Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024 provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Cl ... Read More

• Augmented Reality in Healthcare - Thematic Research

  Mar 22, 2024  |  Published by: GlobalData  |  USD 995

  Augmented Reality in Healthcare - Thematic Research Summary Augmented reality (AR) is a technology that allows the user to see the real world overlaid with digital data. According to GlobalData forecasts, the AR market will be worth $100 billion by 2030, up from $22 billion in 2022. Rather than enab ... Read More

• Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success

  Mar 19, 2024  |  Published by: GlobalData  |  USD 495

  Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success Summary This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements ... Read More

• Cell and Gene Therapies in CNS Disorders

  Mar 18, 2024  |  Published by: GlobalData  |  USD 6,995

  Cell and Gene Therapies in CNS Disorders Summary Currently, there are eight cell and gene therapies (CGT) on the market for various central nervous system (CNS) disorders. This includes three gene therapies, two gene-modified cell therapies, and three conditionally approved cell therapies. Novartis’ ... Read More

• Fragile X Syndrome - Global Clinical Trials Review, 2024

  Mar 18, 2024  |  Published by: GlobalData  |  USD 2,500

  Fragile X Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Fragile X Syndrome - Global Clinical Trials Review, 2024 provides an overview of Fragile X Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Fr ... Read More

• Online Travel - Thematic Research

  Mar 08, 2024  |  Published by: GlobalData  |  USD 995

  Online Travel - Thematic Research Summary This thematic research report takes an in-depth look at the theme of online travel and the impact it has on the travel and tourism industry. This report analyzes the players impacted by this theme alongside the contributing trends, negative destination trend ... Read More

• Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape

  Mar 08, 2024  |  Published by: GlobalData  |  USD 3,495

  Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PCOS therapeutics. More than 54,000,000 total prevalent cases of PCOS are expected in 2024 in the 16 countries covered in GlobalData’s ep ... Read More

• Cell and Gene Therapies in Hemophilia A & B

  Feb 29, 2024  |  Published by: GlobalData  |  USD 6,995

  Cell and Gene Therapies in Hemophilia A & B Summary Clients will gain insight into the competitive landscape of leading CGT agents in Hemophilia A & B including launch date projections, key clinical trial analysis, analyst consensus forecasts, likelihood of approval analysis, and commentary on curre ... Read More

• Female Sexual Dysfunction (FSD) - Competitive Landscape

  Feb 29, 2024  |  Published by: GlobalData  |  USD 3,495

  Female Sexual Dysfunction (FSD) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FSD therapeutics. More than 384,000,000 total prevalent cases of FSD were there in 2023 in the 16 countries covered in GlobalData’s epidemio ... Read More

• Rare Disease ​Pipeline Analysis ​Landscape in 2023

  Feb 28, 2024  |  Published by: GlobalData  |  USD 495

  Rare Disease ​Pipeline Analysis ​Landscape in 2023 Summary This report investigates the Rare Disease ​Pipeline Analysis ​Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via reg ... Read More

• Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Feb 27, 2024  |  Published by: GlobalData  |  USD 4,000

  Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of D ... Read More

• Orthodontic Materials and Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Feb 27, 2024  |  Published by: GlobalData  |  USD 2,500

  Orthodontic Materials and Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Orthodontic Materials and Products Pipeline Report including Stages of Development, ... Read More

• Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Feb 27, 2024  |  Published by: GlobalData  |  USD 4,000

  Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Regi ... Read More

• Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024 provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data rela ... Read More

• Endometriosis - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Endometriosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Endometriosis - Global Clinical Trials Review, 2024 provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Re ... Read More

• Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 provide ... Read More

• Lupus Nephritis - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Lupus Nephritis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Lupus Nephritis - Global Clinical Trials Review, 2024 provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephr ... Read More

• Ewing Sarcoma - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Ewing Sarcoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2024 provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Re ... Read More

• Phenylketonuria (PKU) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Phenylketonuria (PKU) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Phenylketonuria (PKU) - Global Clinical Trials Review, 2024 provides an overview of Phenylketonuria (PKU) Clinical trials scenario. This report provides top line data relating to the clinical tri ... Read More

• Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024 provides an overview of Mucopolysaccharidosis II (MPS II) (Hunter Syndrom ... Read More

• Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This r ... Read More

< prev 12 13 14 15 16 17 18 19 20 21 next >